Related Experiment Video
Updated: Sep 22, 2025

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
Published on: May 16, 2017
Ribosome inhibition by C9ORF72-ALS/FTD-associated poly-PR and poly-GR proteins revealed by cryo-EM
Anna B Loveland1, Egor Svidritskiy1, Denis Susorov1
1RNA Therapeutics Institute, UMass Chan Medical School, 368 Plantation Street, Worcester, MA, 01605, USA.
Abstract:
Toxic dipeptide-repeat (DPR) proteins are produced from expanded G4C2 repeats in the C9ORF72 gene, the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Two DPR proteins, poly-PR and poly-GR, repress cellular translation but the molecular mechanism remains unknown. Here we show that poly-PR and poly-GR of ≥20 repeats inhibit the ribosome's peptidyl-transferase activity at nanomolar concentrations, comparable to specific translation inhibitors. High-resolution cryogenic electron microscopy (cryo-EM) reveals that poly-PR and poly-GR block the polypeptide tunnel of the ribosome, extending into the peptidyl-transferase center (PTC). Consistent with these findings, the macrolide erythromycin, which binds in the tunnel, competes with poly-PR and restores peptidyl-transferase activity. Our results demonstrate that strong and specific binding of poly-PR and poly-GR in the ribosomal tunnel blocks translation, revealing the structural basis of their toxicity in C9ORF72-ALS/FTD.
Insights
Toxic dipeptide-repeat proteins from the C9ORF72 gene block ribosome function. These proteins, poly-PR and poly-GR, inhibit translation by physically obstructing the ribosomal tunnel, explaining their toxicity in neurodegenerative diseases.
Area of Science:
- Molecular Biology
- Neuroscience
- Genetics
Background:
- The C9ORF72 gene mutation is the leading genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
- Toxic dipeptide-repeat (DPR) proteins, including poly-PR and poly-GR, are produced from these expanded G4C2 repeats.
- The mechanism by which these DPR proteins repress cellular translation and cause toxicity is not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanism by which poly-PR and poly-GR inhibit cellular translation.
- To determine the structural basis for the toxicity of these DPR proteins in C9ORF72-associated neurodegenerative diseases.
Main Methods:
- Utilized cryogenic electron microscopy (cryo-EM) to visualize the interaction of DPR proteins with ribosomes.
- Assessed the peptidyl-transferase activity of ribosomes in the presence of poly-PR and poly-GR.
- Investigated the competitive binding between DPR proteins and the known ribosomal inhibitor erythromycin.
Main Results:
- Poly-PR and poly-GR proteins, with at least 20 repeats, inhibit ribosome peptidyl-transferase activity at nanomolar concentrations.
- Cryo-EM revealed that these DPR proteins bind within the ribosome's polypeptide tunnel, obstructing the peptidyl-transferase center (PTC).
- Erythromycin binding in the tunnel competed with poly-PR, restoring peptidyl-transferase activity, indicating a shared binding site.
Conclusions:
- Poly-PR and poly-GR exert toxicity by strongly and specifically binding within the ribosomal tunnel, thereby blocking translation.
- This study reveals the structural mechanism underlying DPR protein toxicity in C9ORF72-ALS and FTD.
- Understanding this mechanism offers potential therapeutic targets for these devastating neurodegenerative diseases.
Related Concept Videos
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Translation
Translation Produces the Building Blocks of Life
Proteins are...

